Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Glycosylation independent lysosomal targeting tagged recombinant human acid alpha glucosidase

EU orphan designation number: EU/3/11/921   
Active ingredient: Glycosylation independent lysosomal targeting tagged recombinant human acid alpha glucosidase
Indication: Treatment of glycogen storage disease type II (Pompe's disease)
Sponsor: BioMarin Europe Ltd
164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/11/2011 Centralised Orphan - Designation EMA/OD/057/11 (2011)7910 of 27/10/2011